ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Donor Specific Antibody Used to Predict Crossmatch Results: A Clinically Useful Algorithm Derived from the College of American Pathologists Survey.

S. Wrenn,1 D.-S. Hain,2 S. Harm,2 S. Hillyard,2 D. Shah,2 P. Hammond,2 C. Marroquin,1 M. Fung.2

1Transplant Surgery, University of Vermont Medical Center, Burlington, VT
2Pathology, University of Vermont Medical Center, Burlington, VT.

Meeting: 2016 American Transplant Congress

Abstract number: B87

Keywords: Histocompatibility antigens, HLA matching

Session Information

Session Name: Poster Session B: Donor Management: All Organs

Session Type: Poster Session

Date: Sunday, June 12, 2016

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Purpose: While there are multiple modalities to perform a preoperative crossmatch for organ transplant surgery, the cytotoxic crossmatch remains the gold standard for detection of incompatible allografts. Solid phase immunoassays such as Luminex technology allow for virtual crossmatching, potentially decreasing cost and time in the preoperative evaluation. However the clinical reliability of the virtual crossmatch remains unclear.

Methods: We performed a retrospective review of the College of American Pathologists HLA Surveys from 2011-2014, which are sent to transplant institutions as an accreditation tool. Each involves a standard sample of cells and serum tested using the preferred crossmatch approach of participating centers. These include direct complement-directed cytotoxicity, anti-human globulin (AHG) augmented, and flow cytometry. Our HLA laboratory performed solid phase immunoassay (Luminex) on all samples to detect for the presence of donor-specific antibodies (DSA), and quantified the relative strength and quantity of each DSA using the mean fluorescent intensity (MFI). Using these data, we compared the cumulative MFI to the national crossmatch results.

Results: A total of 144 survey results were analyzed over the time period. Direct, AHG, and flow crossmatches all had strong direct nonlinear correlation with the Luminex cumulative MFI (r2=0.8, 0.88, and 0.87 respectively). For MFI of 0, less than 5000, 5000-10,000, and 10,000-15,000, there were probabilities of a positive AHG-crossmatch of 3.3, 5.2, 38.8, and 60.7%, respectively.

Conclusions: We present an algorithm and predictive tool that can be replicated nationally at transplant centers that participate in the College of American Pathologists survey. Comparing DSA data on standardized anonymous blood samples against nationally performed crossmatches can help predict the probabilities of these laboratory outcomes, which may assist clinicians in the preoperative transplant workup.

CITATION INFORMATION: Wrenn S, Hain D.-S, Harm S, Hillyard S, Shah D, Hammond P, Marroquin C, Fung M. Donor Specific Antibody Used to Predict Crossmatch Results: A Clinically Useful Algorithm Derived from the College of American Pathologists Survey. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Wrenn S, Hain D-S, Harm S, Hillyard S, Shah D, Hammond P, Marroquin C, Fung M. Donor Specific Antibody Used to Predict Crossmatch Results: A Clinically Useful Algorithm Derived from the College of American Pathologists Survey. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/donor-specific-antibody-used-to-predict-crossmatch-results-a-clinically-useful-algorithm-derived-from-the-college-of-american-pathologists-survey/. Accessed May 9, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences